Drug class

Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type

The phrase "Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type" represents an administrative or compendial formulary grouping rather than a single standardized pharmacological drug class. Read more about Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type

151 drugs in this class 76 manufacturers

Advertisement

Drugs in Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type

Showing 136–144 of 151 drugs

VARENICLINE TARTRATE

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION
GSK Consumer Healthcare

VARENICLINE TARTRATE

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION
DR.REDDY'S LAB

NICODERM CQ (nicotine)

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION
GSK/Haleon US

VARENICLINE TARTRATE

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION
MACLEODS PHARMA
Filter & compare in the drug finder → Opens the drug finder with Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type preselected. Add indication or manufacturer filters there.

About Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type.

The phrase "Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type" represents an administrative or compendial formulary grouping rather than a single standardized pharmacological drug class.

It aggregates distinct therapeutic modalities used as pharmacotherapies for tobacco use disorder and smoking cessation: nicotine replacement therapy and non-nicotine oral therapy.

Nicotinic agents deliver controlled doses of nicotine to stimulate central nicotinic acetylcholine receptors and alleviate acute withdrawal symptoms, whereas bupropion acts as a norepinephrine-dopamine reuptake inhibitor and nicotinic receptor antagonist that reduces cravings and withdrawal independently of nicotine.

Clinically, these agents are indicated as aids to smoking cessation to support tobacco abstinence in adults.